市場調査レポート

商品コード

1454165

コレラワクチンの世界市場規模、シェア、成長分析、エンドユーザー別、タイプ別-産業予測、2024～2031年

Global Cholera Vaccines Market Size, Share, Growth Analysis, By End user(Hospitals, specialty clinics), By Type(Dukoral, Shanchol) - Industry Forecast 2024-2031

出版日: 2024年03月09日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 832,842円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 974,268円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,115,694円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
目次

概要

サンプル依頼リストに入れる

コレラワクチンの世界市場規模は2022年に736億9,000万米ドルと評価され、2023年の790億7,000万米ドルから2031年には1,389億3,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは7.3%で成長する展望です。

コレラの原因となり腸を損傷する細菌感染は、汚染された食品や水によって広がります。筋肉のけいれんや口、のど、鼻、まぶたの内側の粘膜の乾燥のほか、激しい下痢、発熱、脱水症状、腹部の痛み、心拍の速さ、皮膚の弾力性低下、低血圧、心拍の速さなどを引き起こします。現在、世界の公衆衛生がこの感染症によって脅かされているが、予防接種によって食い止めることができます。ワクチンは、生きたコレラ菌のごく少量に体をさらすことで、体が免疫を獲得するのを助ける。ワクチンは経口、静脈内、筋肉内投与が可能です。ワクチン接種とは、特定の感染症に対する免疫を獲得し、免疫系の発達を助ける生物学的製剤です。ワクチンは、世界保健機関（WHO）を含む多くの国際機関で、感染症の治療に使用されています。コレラは、コレラ菌に汚染された水を飲食することで発症する感染力の強い病気です。潜伏期間は数時間から5日と短く、大量の水様性下痢が特徴です。コレラは時に死に至ることもあります。この病気は、不衛生、不十分な消毒、清潔な飲料水の不足と密接な関係があります。この病気は、流行傾向または風土病の傾向をたどることがあります。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

コレラワクチンの世界市場：エンドユーザー別

市場概要
病院
専門クリニック
研究、学術研究所、製薬とバイオテクノロジー企業など

コレラワクチンの世界市場：タイプ別

市場概要
デュコラル
シャンチョル
ヴァクチョーラ
ユービコル
その他

コレラワクチンの世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Sanofi S.A.
GlaxoSmithKline plc
PaxVax Inc.（現Emergent BioSolutionsの一部）
Bharat Biotech
Valneva SE
EuBiologics Co. Ltd.
Shantha Biotechnics Private Limited（Sanofi Pasteurの一部）
Bio Farma（Indonesia Vaccine Institute）
Eubiologics Co. Ltd.
Merck & Co., Inc.
Cipla Limited
Astellas Pharma Inc.
Takeda Pharmaceutical Company Limited
Panacea Biotec Ltd.
Serum Institute of India Pvt. Ltd.
Beijing Minhai Biotechnology Co. Ltd.
Biken Corporation
OCV Consortium（The Bill, Melinda Gates Foundation, WHOなど）
PaxVax Bermuda Ltd.
GSK Biologicals SA.

Product Code: SQMIG35I2103

Global Cholera Vaccines Market size was valued at USD 73.69 billion in 2022 and is poised to grow from USD 79.07 billion in 2023 to USD 138.93 billion by 2031, growing at a CAGR of 7.3% during the forecast period (2024-2031).

The bacterial infections that cause cholera and damage the intestines are spread by contaminated food and water. Apart from cramping in the muscles and dryness of mucous membranes on the inside of the mouth, throat, nose, and eyelids, it also results in severe diarrhea, fever, dehydration, pain in the abdomen, rapid heartbeat, elasticity loss in the skin, low blood pressure, and fast heartbeat. Global public health is currently threatened by it, but immunization can halt it. By exposing the body to a tiny amount of live cholera bacteria, the vaccine helps the body acquire immunity. It can be taken orally, intravenously, or intramuscularly. A vaccination is a biological preparation that provides immunity to certain infectious diseases and aids in the development of the immune system. Vaccines are used to treat infectious diseases by a number of international organizations, including the World Health Organization (WHO). Cholera is a highly contagious disease that is caused by eating or drinking water contaminated with the vibrio cholera bacteria. The infection has a short incubation period of a few hours to five days and is characterized by abundant watery diarrhea. Cholera can occasionally prove fatal. The illness is closely linked to poor hygiene, insufficient sanitization, and a scarcity of clean drinking water. It can follow either an epidemic or an endemic trend.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholera Vaccines Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholera Vaccines Market Segmental Analysis

The product type, administration method, end users, distribution channel, and geographic regions are the factors that divide the worldwide market for cholera vaccines. The cholera vaccines market is divided into three categories based on type: shanchol, euvichol, and dukoral. The market is split into oral and other categories based on the method of administration. The market is divided into end-user segments based on the following: hospitals, research & academic labs, pharmaceutical & biotechnology companies, specialty clinics, and others. The cholera vaccines market has also been divided into hospital pharmacies, retail pharmacies, and other segments based on the distribution channel.

Drivers of the Global Cholera Vaccines Market

The factors predicted to drive the growth of the cholera vaccines market are the creation of novel vaccine delivery systems, raised public knowledge of cholera preventative care, and the adoption of unhealthy lifestyle practices such inadequate sanitation and the consumption of tainted food. Furthermore, the government's increased emphasis on immunization campaigns has propelled the cholera vaccine market's growth. However, the FDA's more stringent standards and drawn-out clearance procedure for novel medications could pose a challenge to the global market for cholera vaccines.

Restraints in the Global Cholera Vaccines Market

Vaccines take a long time to produce, and the need for strict regulatory approvals is projected to impede market expansion over the projection period.

Market Trends of the Global Cholera Vaccines Market

The rising incidence of cholera in the general population is the main factor driving the global market. This is a result of the inadequate hygienic and sanitation conditions in rural and isolated locations. In addition, increased public knowledge of the existence of cholera vaccinations has increased demand for the product.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Cholera Vaccines Market by End user

Market Overview
Hospitals
specialty clinics
research and academic laboratories and pharmaceutical and biotechnology companies and others

Global Cholera Vaccines Market by Type

Market Overview
Dukoral
Shanchol
Vaxchora
Euvichol
and others

Global Cholera Vaccines Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PaxVax Inc. (now part of Emergent BioSolutions)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bharat Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Valneva SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EuBiologics Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shantha Biotechnics Private Limited (part of Sanofi Pasteur)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Farma (Indonesia Vaccine Institute)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eubiologics Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panacea Biotec Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Serum Institute of India Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing Minhai Biotechnology Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biken Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OCV Consortium (The Bill and Melinda Gates Foundation, WHO, and others)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PaxVax Bermuda Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GSK Biologicals SA.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments